Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Slater

Thoracic Surgery (Cardiothoracic Vascular Surgery) Morristown, NJ Medical Doctor

NPI 1841292232 CMS profile 129289

100 Madison Ave, Mid Atlantic Surgical Assoc, Morristown, NJ 07960

Open in the dashboard

General payments

$10,587

302 records reported · program years 2019–2025

Research payments

$4,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Slater of Morristown, NJ is reported in the CMS Open Payments database as having received $10,587 across 302 general payments and $4,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 74th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,791 80
2024 General $1,394 66
2023 General $1,464 42
2022 General $651 26
2021 General $1,395 33
2020 General $535 13
2020 Research $4,000 1
2019 General $3,357 42

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Slater
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to James Slater were reported at $1,791. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year James Slater Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $3,357 $886 $178–$3,167 $163
2020 $535 $341 $108–$1,605 $114
2021 $1,395 $453 $125–$1,886 $132
2022 $651 $695 $180–$2,566 $149
2023 $1,464 $745 $205–$2,662 $160
2024 $1,394 $799 $214–$2,967 $164
2025 $1,791 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $3,631 130 payments
  2. Medtronic Vascular, Inc. $2,345 25 payments
  3. Abbott Laboratories $1,739 41 payments
  4. Medtronic, Inc. $1,071 66 payments
  5. Atricure, Inc. $770 18 payments
  6. Abiomed $510 7 payments
  7. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $169 2 payments
  8. Baxter Healthcare $68 3 payments
  9. Zimmer Biomet Holdings, Inc. $63 1 payment
  10. Becton, Dickinson and Company $48 1 payment
  11. Other $173 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,627 295 payments
  2. Travel and Lodging $1,678 6 payments
  3. Long term medical supply or device loan $282 1 payment
Products named General payments · program years 2019–2025
  1. SAPIEN 3 Ultra RESILIA $2,482 104 payments
  2. COREVALVE EVOLUT R $795 53 payments
  3. Impella $510 7 payments
  4. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $427 10 payments
  5. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $386 14 payments
  6. CentriMag $369 3 payments
  7. PORTICO $315 3 payments
  8. INSPIRIS RESILIA aortic valve $311 2 payments
  9. ATRICLIP LAA EXCLUSION SYSTEM $302 9 payments
  10. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $277 5 payments
  11. Other $2,637 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $4,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

29

Median for Cardiac Surgery: 68

Drug cost

$295

Median for Cardiac Surgery: $445

Branded share of claims

0%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 29 $295

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$217,022

Medicare's payments for the services billed

Medicare patients

209

Average age 77

Services billed

463

70 women, 139 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Chronic kidney disease 73%
Atrial fibrillation 49%
Arthritis 49%
Diabetes 48%
Cancer 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

303 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record